Bank of Nova Scotia vs ResMed Inc. — how do they compare? Bank of Nova Scotia trades at $89.03 (market cap $108.32B), while ResMed Inc. trades at $220.4 (market cap $32.61B). The key difference: Bank of Nova Scotia is far larger — about 3.3× ResMed Inc.'s market cap, and Bank of Nova Scotia pays the higher dividend (3.64%). Which is the better fit depends on your goals.
| BNS | RMD | |
|---|---|---|
Market Cap | $108.32B | $32.61B |
Sector | Financials | Health |
52-Week High | $90.29 | $293.73 |
52-Week Low | $56.41 | $182.82 |
Dividend Yield | 3.64% | 1.17% |
Enterprise Value | — | $31.97B |
Trailing returns across standard periods
Bank of Nova Scotia is a global financial services provider. The bank has five business segments: Canadian banking, international banking, global wealth management, global banking and markets, and other. It offers a range of advice, products, and services, including personal and commercial banking, wealth management and private banking, corporate and investment banking, and capital markets. The bank's international operations span numerous countries and are more concentrated in Central and South America.
Read more on BNS →ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →